Rchr
J-GLOBAL ID:202001015232421642   Update date: Feb. 08, 2024

Hamaguchi Isao

ハマグチ イサオ | Hamaguchi Isao
Affiliation and department:
Job title: 部長
Research theme for competitive and other funds  (7):
  • 2018 - 2021 Elucidation of the mechanism of latent HTLV-1 infection for preventing from ATL onset of HTLV-1 carriers
  • 2015 - 2018 Development of HTLV-1 carrier model mice aming for preventing ATL development
  • 2012 - 2015 Identification and functional analysis of ATL cancer stem cells using a humanized mice
  • 2009 - 2011 Development of the biomarker for th e clinical diagnosis of Diamond-Blackfan Anemia
  • 2007 - 2008 Identification of the common factors specific for tissue stem cells and the functional analysis of them
Show all
Papers (155):
  • Koh Nagata, Kenta Tezuka, Madoka Kuramitsu, Naoki Fuchi, Yuri Hasegawa, Isao Hamaguchi, Kiyonori Miura. Establishment of a novel human T-cell leukemia virus type 1 infection model using cell-free virus. Journal of virology. 2024. e0186223
  • Haruka Momose, Asako Murayama, Norie Yamada, Keiji Matsubayashi, Sahoko Matsuoka, Emi Ikebe, Madoka Kuramitsu, Masamichi Muramatsu, Takanobu Kato, Isao Hamaguchi. Performance evaluation of in vitro diagnostic kits for hepatitis B virus infection using the regional reference panel of Japan. Virology Journal. 2023. 20. 1
  • Madoka Kuramitsu, Haruka Momose, Yuichiro Uchida, Kenji Ishitsuka, Ryuji Kubota, Masahito Tokunaga, Atae Utsunomiya, Kunihiko Umekita, Yuuki Hashikura, Kisato Nosaka, et al. Performance evaluation of Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test for different diagnostic situations. Microbiology spectrum. 2023. e0207823
  • Sho Saito, Satoshi Kutsuna, Imamura Akifumi, Ryota Hase, Rentaro Oda, Junko Terada, Yosuke Shimizu, Yukari Uemura, Yuki Takamatsu, Akemi Yasuhara, et al. Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023. 29. 9. 869-874
  • Eita Sasaki, Hideki Asanuma, Haruka Momose, Keiko Furuhata, Takuo Mizukami, Takayuki Matsumura, Yoshimasa Takahashi, Isao Hamaguchi. Systemically inoculated adjuvants stimulate pDC-dependent IgA response in local site. Mucosal immunology. 2023
more...
MISC (76):
  • 浜口 功, 池辺 詠美, 松岡 佐保子. 教育講演13 ヘモビジランス・トレーサビリティについて-第45回日本血液事業学会総会. 血液事業. 2022. 45. 1. 236-241
  • 佐々木永太, 水上拓郎, 浜口功. Vaccine adjuvant design from safety studies. 医学のあゆみ. 2021. 279. 10
  • 手塚健太, 浜口功. HTLV-1 targets human placental trophoblasts in seropositive pregnant women. 月刊臨床免疫・アレルギー科. 2021. 75. 6
  • 大隈和, 手塚健太, 浜口功. 輸血用血液製剤と血漿分画製剤の安全性確保と安定供給のための新興・再興感染症の研究 血液からの重症熱性血小板減少症候群ウイルス等の検出法確立に関する研究. 輸血用血液製剤と血漿分画製剤の安全性確保と安定供給のための新興・再興感染症の研究 令和元年度 総括・分担研究報告書(Web). 2020
  • 大隈和, 倉光球, 手塚健太, 水上拓郎, 村田めぐみ, 明里宏文, 浜口功. STLV-1感染ニホンザルによるHTLV-1標的ウイルス療法の開発に向けた検討. 日本実験動物学会総会講演要旨集(Web). 2020. 67th
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page